GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Cyclically Adjusted PB Ratio

Kaken Pharmaceutical Co (TSE:4521) Cyclically Adjusted PB Ratio : 1.12 (As of May. 22, 2024)


View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio?

As of today (2024-05-22), Kaken Pharmaceutical Co's current share price is 円3436.00. Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was 円3,079.64. Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is 1.12.

The historical rank and industry rank for Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4521' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.06   Med: 2.04   Max: 3.7
Current: 1.12

During the past years, Kaken Pharmaceutical Co's highest Cyclically Adjusted PB Ratio was 3.70. The lowest was 1.06. And the median was 2.04.

TSE:4521's Cyclically Adjusted PB Ratio is ranked better than
68.99% of 674 companies
in the Drug Manufacturers industry
Industry Median: 1.855 vs TSE:4521: 1.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kaken Pharmaceutical Co's adjusted book value per share data for the three months ended in Dec. 2023 was 円3,700.432. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円3,079.64 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.61 2.38 1.87 1.51 1.29

Kaken Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 1.29 1.23 1.16 1.09

Competitive Comparison of Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=3436.00/3079.64
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Kaken Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3700.432/106.8000*106.8000
=3,700.432

Current CPI (Dec. 2023) = 106.8000.

Kaken Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 1,611.715 95.700 1,798.654
201406 1,589.230 98.000 1,731.936
201409 1,642.864 98.500 1,781.298
201412 1,708.521 97.900 1,863.841
201503 1,861.066 97.900 2,030.254
201506 1,952.070 98.400 2,118.710
201509 2,065.909 98.500 2,239.991
201512 2,224.236 98.100 2,421.492
201603 2,170.565 97.900 2,367.889
201606 2,174.864 98.100 2,367.742
201609 2,287.989 98.000 2,493.441
201612 2,387.395 98.400 2,591.197
201703 2,511.640 98.100 2,734.385
201706 2,564.274 98.500 2,780.350
201709 2,688.583 98.800 2,906.282
201712 2,767.934 99.400 2,973.997
201803 2,824.280 99.200 3,040.656
201806 2,820.949 99.200 3,037.070
201809 2,950.215 99.900 3,153.984
201812 2,977.235 99.700 3,189.255
201903 3,049.751 99.700 3,266.935
201906 3,067.364 99.800 3,282.510
201909 3,165.166 100.100 3,377.020
201912 3,251.768 100.500 3,455.610
202003 3,301.042 100.300 3,514.968
202006 3,340.349 99.900 3,571.064
202009 3,417.024 99.900 3,653.035
202012 3,444.324 99.300 3,704.469
202103 3,555.890 99.900 3,801.492
202106 3,561.796 99.500 3,823.114
202109 3,657.705 100.100 3,902.526
202112 3,678.438 100.100 3,924.647
202203 3,642.275 101.100 3,847.626
202206 3,643.005 101.800 3,821.935
202209 3,730.790 103.100 3,864.679
202212 3,739.332 104.100 3,836.318
202303 3,636.148 104.400 3,719.738
202306 3,662.727 105.200 3,718.434
202309 3,755.461 106.200 3,776.678
202312 3,700.432 106.800 3,700.432

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kaken Pharmaceutical Co  (TSE:4521) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kaken Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kaken Pharmaceutical Co (TSE:4521) Business Description

Traded in Other Exchanges
Address
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines